Hosford-Dunn et al.(1212 Hosford-Dunn H, Johnson S, Simmons FB, Malachowski N, Low K. Infant hearing screening: program implementation and validation. Ear Hear. 1987;8(1):12-20. http://dx.doi.org/10.1097/00003446-198702000-00003. PMid:3549402. http://dx.doi.org/10.1097/00003446-19870...
)
|
longitudinal |
- |
USA |
With RFHL |
VRA, “play audiometry” “Crib-0-Gram”. |
1 year, 2 or 3 years. Complete audiological follow-up at 3 years old |
Tucker & Bhattacharya(1313 Tucker SM, Bhattacharya J. Screening of hearing impairment in the newborn using the auditory response cradle. Arch Dis Child. 1992;67(7):911-9. http://dx.doi.org/10.1136/adc.67.7.911. PMid:1519957. http://dx.doi.org/10.1136/adc.67.7.911...
)
|
not declared |
To assess ARC for severe bilateral HL |
England |
With and without RFHL |
ARC |
7 to 9 months, 18 months and complete audiological follow-up at 3 years old |
Fowler et al.(1414 Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr. 1999;135(1):60-4. http://dx.doi.org/10.1016/S0022-3476(99)70328-8. PMid:10393605. http://dx.doi.org/10.1016/S0022-3476(99)...
)
|
coorte |
To predict whether the UNHS would identify SNHL caused by CMV |
USA |
CMV |
Frequency-specific ABR, behavioral audiometry, speech audiometry, immitanciometry |
3 to 8 weeks, 6 and 12 months and posteriorly, “annually” |
Norton et al.(1515 Norton SJ, Gorga MP, Widen JE, Folsom RC, Sininger Y, Cone-Wesson B, et al. Identification of neonatal hearing impairment: summary and recommendations. Ear Hear. 2000;21(5):529-35. http://dx.doi.org/10.1097/00003446-200010000-00014. PMid:11059708. http://dx.doi.org/10.1097/00003446-20001...
)
|
prospective multicenter |
To determine the performance characteristics of TOAE, DPOAE ABR, at the corrected ages of 8 to 12 months |
USA |
With IRDA |
VRA |
8 to 12 months of corrected age |
Norton et al.(1616 Norton SJ, Gorga MP, Widen JE, Folsom RC, Sininger Y, Cone-Wesson B, et al. Identification of neonatal hearing impairment: a multicenter investigation. Ear Hear. 2000;21(5):348-56. http://dx.doi.org/10.1097/00003446-200010000-00003. PMid:11059697. http://dx.doi.org/10.1097/00003446-20001...
)
|
prospective multicenter |
To determine the accuracy of TOAE, DPOAE and ABR to predict behavioral hearing status at 8 to 12 months of corrected age |
USA |
With IRDA |
VRA |
8 to 12 months of corrected age |
Ari-Even Roth et al.(1717 Ari-Even Roth D, Hildesheimer M, Maayan-Metzger A, Muchnik C, Hamburger A, Mazkeret R, et al. Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening. Arch Dis Child Fetal Neonatal. 2006;91(4):F257-62. http://dx.doi.org/10.1136/adc.2005.074476. PMid:16531449. http://dx.doi.org/10.1136/adc.2005.07447...
)
|
coorte |
To study the prevalence of HL in newborns with ELW at birth and evaluate the effectiveness of TOAE as a screening tool |
Israel |
Premature/low weight |
bone ABR and click ABR |
1 month after discharge and audiological follow-up in “regular periods” up to 3 years |
Iwasakiet al.(1818 Iwasaki S, Yamashita M, Maeda M, Misawa K, Mineta H. Audiological outcome of infants with congenital cytomegalovirus infection in a prospective study. Audiol Neurotol. 2007;12(1):31-6. http://dx.doi.org/10.1159/000096156. PMid:17033163. http://dx.doi.org/10.1159/000096156...
)
|
prospective |
To assess the audiological outcome of long-term follow-up of infants with asymptomatic CMV infection |
Japan |
CMV |
Frequency-specific ABR, behavioral audiometry |
Intervals from 6-12 months to 4 years |
Barboza et al.(99 Barboza ACS, Resende LM, Ferreira DBC, Lapertosa CZ, Carvalho SAS. Correlação entre perda auditiva e indicadores de risco em um serviço de referência em triagem auditiva neonatal. Audiol Commun Res. 2013;18(4):285-92. http://dx.doi.org/10.1590/S2317-64312013000400009. http://dx.doi.org/10.1590/S2317-64312013...
)
|
descriptive retrospective |
To verify the occurrence of HL and its correlation with RFHL in babies from a UNHS service |
Brazil |
With RFHL |
ABR |
6 months |
Wilson et al.(1919 Wilson MG, Riley P, Hurteau AM, Baird R, Puligandla PS. Hearing loss in congenital diaphragmatic hernia (CDH) survivors: is it as prevalent as we think? J Pediatr Surg. 2013;48(5):942-5. http://dx.doi.org/10.1016/j.jpedsurg.2013.02.007. PMid:23701764. http://dx.doi.org/10.1016/j.jpedsurg.201...
)
|
retrospective |
To assess long-term audiological outcomes in a neonatal follow-up program |
Canada |
Congenital Diaphragmatic Hernia |
Standard audiometry according to the age, OAE, immitanciometry |
8, 18 months, 3 years |
Beswick et al.(2020 Beswick R, Driscoll C, Kei J, Khan A, Glennon S. Which risk factors predict postnatal hearing loss in children? J Am Acad Audiol. 2013;24(3):205-13. http://dx.doi.org/10.3766/jaaa.24.3.6. PMid:23506665. http://dx.doi.org/10.3766/jaaa.24.3.6...
)
|
retrospective |
To investigate the RFHL most likely to predict the occurrence of postnatal HL |
Australia |
With RFHL |
Otoscopy, tympanometry, ABR, VRA, DPOAE and TOAE, “play audiometry”. Tests chosen according to the age of the children. |
RFHL congenital infection: 3, 6 months and then every 6 months until 2 years, with discharge assessment within 3 years. RFHL family history: at 6 months and then every 6 months until 2 years, with discharge assessment at 3. Missing RFHL: single consultation from 9 to 12 months and then discharge assessment at 3.5 years old |
Wood et al.(2121 Wood SA, Sutton GJ, Davis AC. Performance and characteristics of the Newborn Hearing Screening Programme in England: the first seven years. Int J Audiol. 2015;54(6):353-8. http://dx.doi.org/10.3109/14992027.2014.989548. PMid:25766652. http://dx.doi.org/10.3109/14992027.2014....
)
|
retrospective |
To evaluate the UNHS performance in England |
England |
Newborns that passed the a-ABR but not in the TOAE |
- |
8 months |
Karimian et al.(2222 Karimian P, Yaghini O, Nasr Azadani H, Mohammadizadeh M, Arabzadeh SA, Adibi A, et al. Prevalence, characteristics, and one-year follow-up of congenital cytomegalovirus infection in Isfahan City, Iran. Interdiscip Perspect Infect Dis. 2016;2016:7812106. http://dx.doi.org/10.1155/2016/7812106. PMid:28070187. http://dx.doi.org/10.1155/2016/7812106...
)
|
prospective |
To assess the prevalence and the prognosis of the cCMV infection in Iran |
Iran |
CMV |
ABR |
ABR at 12 months. Regular visits at 2, 4, 6, 9 and 12 months |
Yılmazer et al.(2323 Yılmazer R, Yazıcı MZ, Erdim İ, Kaya HK, Özcan Dalbudak Ş, Kayhan TF. Follow-up results of newborns after hearing screening at a training and research hospital in Turkey. J Int Adv Otol. 2016;12(1):55-60. http://dx.doi.org/10.5152/iao.2015.1736. PMid:27340984. http://dx.doi.org/10.5152/iao.2015.1736...
)
|
not declared |
To present the results of the follow-up of NB after UNHS and determine the age of diagnosis, adaptation of hearing aids and cochlear implant in NB with HL |
Turkey |
With RFHL |
a-ABR |
1 week |
Molini et al.(2424 Molini E, Calzolaro L, Lapenna R, Ricci G. Universal newborn hearing screening in Umbria region, Italy. Int J Pediatr Otorhinolaryngol. 2016;82:92-7. http://dx.doi.org/10.1016/j.ijporl.2016.01.007. PMid:26857323. http://dx.doi.org/10.1016/j.ijporl.2016....
)
|
retrospective |
To examine the results of the program and its evolution in the first 2.5 years of implementation |
Italy |
With RFHL |
- |
6 in 6 meses, up to 3 years |
Sabbag & Lacerda(2525 Sabbag JC, Lacerda ABM. Rastreamento e monitoramento da Triagem Auditiva Neonatal em Unidade de Estratégia de Saúde da Família: estudo-piloto. CoDAS. 2017;29(4):e20160102. http://dx.doi.org/10.1590/2317-1782/20172016102. PMid:28813070. http://dx.doi.org/10.1590/2317-1782/2017...
)
|
observational, retrospective and quantitative |
To analyze the flow of the UNHS in FHS through tracking and monitoring of children |
Brazil |
With and without RFHL |
Interview |
0-1 year |
Dumanch et al.(2626 Dumanch KA, Holte L, O’Hollearn T, Walker E, Clark J, Oleson J. High risk factors associated with early childhood hearing loss: a 3-year review. Am J Audiol. 2017;26(2):129-42. http://dx.doi.org/10.1044/2017_AJA-16-0116. PMid:28475714. http://dx.doi.org/10.1044/2017_AJA-16-01...
)
|
retrospective |
To analyze the association between the RFHL and audiological status in early childhood and the follow-up rates of children approved or referred by RFHL |
USA |
With RFHL |
- |
3 years |
Turchetta et al.(2727 Turchetta R, Conti G, Marsella P, Orlando MP, Picciotti PM, Frezza S, et al. Universal newborn hearing screening in the Lazio region, Italy. Ital J Pediatr. 2018;44(1):104. http://dx.doi.org/10.1186/s13052-018-0534-5. PMid:30143030. http://dx.doi.org/10.1186/s13052-018-053...
)
|
retrospective |
To present and discuss the preliminary results of the UNHS program in the Lazio region |
Italy |
With RFHL |
TOAE, ABR, immitanciometry |
6 in 6 months for the first 3 years, then annually for the next 3 years |
Foulon et al.(2828 Foulon I, Brucker Y, Buyl R, Lichtert E, Verbruggen K, Piérard D, et al. Hearing loss with congenital cytomegalovirus infection. Pediatrics. 2019 Ago;144(2):e20183095. http://dx.doi.org/10.1542/peds.2018-3095. PMid:31266824. http://dx.doi.org/10.1542/peds.2018-3095...
)
|
prospective |
To determine the prevalence of HL in children with CMV. To analyze the possible determinants RFHL and to propose recommendations to NB screening and follow-up. |
Belgium |
CMV |
- |
Between 5 and 12 months, then annually until 4 years |
Schaefer et al.(2929 Schaefer K, Coninx F, Fischbach T. LittlEARS auditory questionnaire as an infant hearing screening in Germany after the newborn hearing screening. Int J Audiol. 2019;58(8):468-75. http://dx.doi.org/10.1080/14992027.2019.1597287. PMid:31012791. http://dx.doi.org/10.1080/14992027.2019....
)
|
not declared |
To investigate the feasibility to use the LittlEARS® Auditory Questionnaire (LEAQ®) as part of the newborn hearing screening program in Germany |
Germany |
With and without RFHL |
Questionnaires and specific exams according to the results |
3 years |
McInerney et al.(3030 McInerney M, Scheperle R, Zeitlin W, Bodkin K, Uhl B. Adherence to follow-up recommendations for babies at risk for pediatric hearing loss. Int J Pediatr Otorhinolaryngol. 2020;132:109900. http://dx.doi.org/10.1016/j.ijporl.2020.109900. PMid:32006864. http://dx.doi.org/10.1016/j.ijporl.2020....
)
|
retrospective |
To assess the adherence of families to the recommendations for continuous monitoring of infants with RFHL |
USA |
With RFHL |
Otoscopy, tympanometry, behavioral audiometry, sound field audiometry, frequency-specific ABR, DPOAE. According to age |
3 and 6, then every 6 months until 24-30 months |
Basonbul et al.(88 Basonbul RA, Ronner EA, Rong A, Rong G, Cohen MS. Audiologic testing in children with Down Syndrome: are current guidelines optimal? Int J Pediatr Otorhinolaryngol. 2020;134:110017. http://dx.doi.org/10.1016/j.ijporl.2020.110017. PMid:32251971. http://dx.doi.org/10.1016/j.ijporl.2020....
)
|
retrospective |
To present auditory results for children with DS during the first 8 years of life and assess these results in the context of current screening guidelines. |
USA |
Down Sindrome |
ABR or behavioral audiometry. According to the child 's development |
6 in 6 months up to 3-4 years. Afterwards annually or when necessary |